Update (June 28, 2018): Cannabis is added to Schedule II of the Natural Health Product Regulations. Contact us for further information. 1-866-647-3279 or firstname.lastname@example.org. Update (June 28, 2018): CBD as […] Read More >>
Regulation of Cannabis in Canada From November 21, 2017 to January 20, 2018, Health Canada launched a 60-day public consultation period for the proposed approach to the regulation of cannabis […] Read More >>
To comply with Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) Good Production Practices (GPP), it is mandatory to report details of all adverse reactions. An adverse drug reaction, […] Read More >>
Public support for medical marijuana in Canada has grown in recent times, and along with it the corresponding industry and market potential. The demand for medical marijuana in increasing in […] Read More >>
On April 11, 2018, Ontario announced the first four locations for cannabis retail stores, provincially run by the LCBO and the Ontario Cannabis Store (OCS), while other provinces had made […] Read More >>
On November 21, 2017, Health Canada released a consultation document titled “Proposed Approach to the Regulation of Cannabis”. The purpose of this consultation document was to solicit public input and […] Read More >>
https://finance.yahoo.com/news/dicentra-demystifies-medical-marijuana-regulations-120700620.html TORONTO, ONTARIO–(Marketwired – Sep 2, 2014) – Medical marijuana has become big business in Canada. dicentra’s online webinar deciphers Read More >>
by Peter Wojewnik Wednesday, August 13, 2014 Toronto- 37,000 Canadians use medical marijuana to soothe a variety of illnesses, including chronic pain, epilepsy, nausea, loss of appetite due to chemotherapy […] Read More >>
MARIHUANA FOR MEDICAL PURPOSES REGULATIONS (MMPR) WEBINAR Understanding the Marihuana for Medical Purposes Regulations (MMPR), Overcoming the Hurdles in Becoming a Licensed Producer of Medical Marihuana, and Understanding Potential Costs […] Read More >>
dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in jurisdictions where cannabis is legal (whether for medical use or recreational use or both) on a federal level. We do not provide any consulting services whatsoever for cannabis-related business conducted in the United States of America, or in any of its States or Territories.
Stay abreast of regulatory updates, news, events, offers and more
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.